Trials / Completed
CompletedNCT02312193
Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 95 (estimated)
- Sponsor
- Neuromed IRCCS · Academic / Other
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Aim of this study is to enhance the knowledge of myogenic tone alterations in hypertensive patients and to better understand the mechanisms controlling the myogenic tone. Evaluations will be performed through ex vivo studies of peripheral arterioles in human adipose tissue from lumbar muscle, isolated from biopsies. This will allow investigators to evaluate the myogenic function in response to progressive blood pressure increases, in order to correlate myogenic function to arterial hypertension and to the molecular mechanisms already identified in the preclinical models.
Conditions
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2014-12-09
- Last updated
- 2022-01-04
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02312193. Inclusion in this directory is not an endorsement.